Occlutech International AB
Occlutech International AB
Explore linked clinical trials.12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, congenital heart disease, headache disorder, heart disorder, heart septal defect, hypnic headache, migraine disorder, nervous system disorder, patent foramen ovale | Recruiting | Phase 3 | 2026-10-08 | NCT07629635 | |
| Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder, patent ductus arteriosus | Recruiting | Not stated | 2026-08-12 | NCT05264753 | |
| A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech Paravalvular Leak Device (PLD) in Patients With Mitral or Aortic Paravalvular Leaks | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, encephalomalacia, nervous system disorder, periventricular leukomalacia, vascular disorder | Enrolling by invitation | Not stated | 2026-07-31 | NCT07037446 | |
| Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder | Recruiting | Not stated | 2026-07-30 | NCT05329350 | |
| The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2026-06-08 | NCT04405583 | |
| Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-05-22 | NCT05069558 | |
| Occlutech AFR Fontan Study | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder, univentricular heart | Not yet recruiting | Not stated | 2026-04-15 | NCT07532369 | |
| Pulmonary Embolism and Right-to-Left Shunts | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Embolism, Embolism and Thrombosis, Pulmonary Arteriovenous Fistulas, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, lung disorder, nervous system disorder, patent foramen ovale, pulmonary embolism, respiratory system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2026-04-09 | NCT07519876 | |
| PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-03-24 | NCT05387954 | |
| A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects | Perimembranous Ventricular Septal Defect | Active, not recruiting | Not stated | 2026-01-16 | NCT04034498 | |
| ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices | cardiovascular disorder, heart disorder | Recruiting | Not stated | 2025-12-04 | NCT05174442 | |
| Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2025-08-08 | NCT05136820 |